Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Vericel

CTech 24/7

  • Are AI tools making us smarter or just lazier?
  • Nothing Phone 3 review: Stylish, capable, but not quite a flagship
  • Nothing Phone 3 review: Stylish, capable, but not quite a flagship
  • From red tape to revenue: The growth of business-to-government partnerships
More stories in CTech

Vericel

1 stories about Vericel
  • MediWound CEO Sharon Malka. Photo: PR

    Burn Treatment Company MediWound Enters Licensing Agreement with Vericel

    10.05.19|Micky GrunfeldThe agreement, for commercial rights in North America to Mediwound’s flagship burn treatment NexoBrid, could net the company up to $150 million

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive